Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Rodondi

Showing results (181-190 of 531) with videos related to

Pageof 54
Sort By:
Revue Medicale Suisse|March 10, 2022
[Polypharmacy and inappropriate medications in multimorbid elderly patients - What OPERAM taught us and will teach us]Lisa Bretagne, Katharina Tabea Jungo, Manuel R Blum, et al.
BMC Geriatrics|November 26, 2025
Prescribing and deprescribing of atypical antipsychotics in older multimorbid patientsClaudio Schneider, Denis O'Mahony, Stephen Byrne, et al.
Plos One|December 11, 2025
Safety outcomes of statin vs non-statin lipid-lowering interventions in patients with prior statin-associated muscle symptoms: A systematic review and meta-analysisPhilipp Stefan Aebi, Fanny Villoz, Jonas Bührer, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2006
Counselling overweight and obese patients in primary care: a prospective cohort studyNicolas Rodondi, Jean-Paul Humair, William A Ghali, et al.
BMC Family Practice|June 23, 2021
Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trialKatharina Tabea Jungo, Rahel Meier, Fabio Valeri, et al.
The American Journal of Cardiology|April 14, 2009
Cardiovascular risk estimation and eligibility for statins in primary prevention comparing different strategiesDavid Nanchen, Arnaud Chiolero, Jacques Cornuz, et al.
BMC Geriatrics|August 19, 2008
The Lausanne cohort Lc65+: a population-based prospective study of the manifestations, determinants and outcomes of frailtyBrigitte Santos-Eggimann, Athanassia Karmaniola, Laurence Seematter-Bagnoud, et al.
The American Journal of Medicine|June 14, 2017
Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?Marie Méan, Andreas Limacher, Odile Stalder, et al.
Addiction (Abingdon, England)|April 3, 2014
Change in physical activity after smoking cessation: the Coronary Artery Risk Development in Young Adults (CARDIA) studyReto Auer, Eric Vittinghoff, Catarina Kiefe, et al.
Annals of Internal Medicine|April 6, 2006
Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitusNicolas Rodondi, Tiffany Peng, Andrew J Karter, et al.
Pageof 54

Showing results (181-190 of 531) with videos related to

Sort By:
Pageof 54
Revue Medicale Suisse|March 10, 2022
[Polypharmacy and inappropriate medications in multimorbid elderly patients - What OPERAM taught us and will teach us]Lisa Bretagne, Katharina Tabea Jungo, Manuel R Blum, et al.
BMC Geriatrics|November 26, 2025
Prescribing and deprescribing of atypical antipsychotics in older multimorbid patientsClaudio Schneider, Denis O'Mahony, Stephen Byrne, et al.
Plos One|December 11, 2025
Safety outcomes of statin vs non-statin lipid-lowering interventions in patients with prior statin-associated muscle symptoms: A systematic review and meta-analysisPhilipp Stefan Aebi, Fanny Villoz, Jonas Bührer, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2006
Counselling overweight and obese patients in primary care: a prospective cohort studyNicolas Rodondi, Jean-Paul Humair, William A Ghali, et al.
BMC Family Practice|June 23, 2021
Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trialKatharina Tabea Jungo, Rahel Meier, Fabio Valeri, et al.
The American Journal of Cardiology|April 14, 2009
Cardiovascular risk estimation and eligibility for statins in primary prevention comparing different strategiesDavid Nanchen, Arnaud Chiolero, Jacques Cornuz, et al.
BMC Geriatrics|August 19, 2008
The Lausanne cohort Lc65+: a population-based prospective study of the manifestations, determinants and outcomes of frailtyBrigitte Santos-Eggimann, Athanassia Karmaniola, Laurence Seematter-Bagnoud, et al.
The American Journal of Medicine|June 14, 2017
Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?Marie Méan, Andreas Limacher, Odile Stalder, et al.
Addiction (Abingdon, England)|April 3, 2014
Change in physical activity after smoking cessation: the Coronary Artery Risk Development in Young Adults (CARDIA) studyReto Auer, Eric Vittinghoff, Catarina Kiefe, et al.
Annals of Internal Medicine|April 6, 2006
Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitusNicolas Rodondi, Tiffany Peng, Andrew J Karter, et al.
Pageof 54